DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Zoulim F, Lenz O, Vandenbossche JJ. et al.
JNJ-56136379, an HBV capsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 study of patients with chronic infection.
Gastroenterology 2020;
159 (02) 521-533.e9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.